CYCLO3PSS CORP
10KSB, EX-27, 2000-05-31
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CYCLO3PSS CORP, 10KSB, EX-23, 2000-05-31
Next: MORGAN STANLEY DEAN WITTER & CO, 424B3, 2000-05-31



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTS FROM
     CYCLO3PSS CORPORATION'S FINANCIAL STATEMENTS AND IS QUALIRIFED IN ITS
     ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>                                   1
<CURRENCY>                                     107,565

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                              FEB-29-2000
<PERIOD-START>                                 MAR-01-1999
<PERIOD-END>                                   FEB-29-2000
<EXCHANGE-RATE>                                1
<CASH>                                         107,565
<SECURITIES>                                   0
<RECEIVABLES>                                  70,723
<ALLOWANCES>                                   23,420
<INVENTORY>                                    17,930
<CURRENT-ASSETS>                               202,033
<PP&E>                                         135,521
<DEPRECIATION>                                 89,648
<TOTAL-ASSETS>                                 466,984
<CURRENT-LIABILITIES>                          1,060,173
<BONDS>                                        0
                          0
                                    366
<COMMON>                                       25,225
<OTHER-SE>                                     (618,780)
<TOTAL-LIABILITY-AND-EQUITY>                   466,984
<SALES>                                        751,542
<TOTAL-REVENUES>                               751,542
<CGS>                                          433,598
<TOTAL-COSTS>                                  1,694,254
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               (942,712)
<INTEREST-EXPENSE>                             (875)
<INCOME-PRETAX>                                (1,960,414)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            0
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                (234,346)
<CHANGES>                                      0
<NET-INCOME>                                   (2,194,760)
<EPS-BASIC>                                  (.11)
<EPS-DILUTED>                                  (.11)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission